Category: Markets
Published: 2026-08-17T17:29:44.000Z
Johnson & Johnson MedTech has launched Monarch Quest 3, the latest software iteration for its Monarch robotically assisted bronchoscopy platform, following FDA 510(k) clearance. This update enhances navigation, control, and targeting assistance for lung biopsies through features like a 3D compass overlay and AI-powered nodule segmentation. The company emphasizes its commitment to advancing the platform to improve outcomes for lung cancer patients amidst increasing competition in the robotic bronchoscopy space.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.